See more : Culpeo Minerals Limited (CPO.AX) Income Statement Analysis – Financial Results
Complete financial analysis of JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of JiangSu WuZhong Pharmaceutical Development Co., Ltd., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Prosper Engineering Public Company Limited (PROS.BK) Income Statement Analysis – Financial Results
- AVZ Minerals Limited (AVZ.AX) Income Statement Analysis – Financial Results
- Tokai Lease Co.,Ltd. (9761.T) Income Statement Analysis – Financial Results
- Kodiak Energy Inc. (KDKN) Income Statement Analysis – Financial Results
- Keysight Technologies, Inc. (KEYS) Income Statement Analysis – Financial Results
JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS)
About JiangSu WuZhong Pharmaceutical Development Co., Ltd.
JiangSu WuZhong Pharmaceutical Development Co., Ltd., together with its subsidiaries, engages in pharmaceutical, real estate, and chemical businesses in China. It develops, produces, and sells anti-infective, digestive system, cardiovascular, cerebrovascular, antiviral, vitamin, and hemostatic drugs; and immunomodulations, including biopharmaceuticals, chemical drugs, and modern Chinese medicines. The company offers its products in various forms, such as infusion solutions, water and powder injections, capsules, granules, tablets, emulsions, and oral liquids. It also engages in the research, development, production, and sale of dyes and dye intermediates; and the fields of commercial housing and affordable housing development. The company was founded in 1994 and is based in Suzhou, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.24B | 2.03B | 1.78B | 1.87B | 2.11B | 1.70B | 2.96B | 3.99B | 2.93B | 3.07B | 3.88B | 3.72B | 3.88B | 3.38B | 2.31B | 2.49B | 2.38B | 1.85B | 1.43B | 1.17B | 1.13B | 666.23M | 668.55M | 414.24M | 301.40M | 304.80M | 212.47M | 229.74M |
| Cost of Revenue | 1.72B | 1.45B | 1.26B | 1.30B | 1.49B | 1.10B | 2.32B | 3.53B | 2.57B | 2.59B | 3.35B | 3.31B | 3.56B | 3.08B | 2.08B | 2.27B | 2.18B | 1.66B | 1.19B | 918.83M | 900.58M | 492.96M | 489.27M | 324.64M | 236.36M | 248.76M | 163.58M | 175.76M |
| Gross Profit | 520.83M | 579.66M | 511.92M | 575.31M | 624.57M | 603.46M | 640.24M | 462.14M | 355.07M | 478.03M | 526.95M | 414.86M | 310.73M | 302.32M | 231.28M | 221.34M | 202.93M | 190.27M | 237.41M | 255.42M | 226.43M | 173.27M | 179.28M | 89.60M | 65.04M | 56.04M | 48.89M | 53.98M |
| Gross Profit Ratio | 23.25% | 28.61% | 28.83% | 30.74% | 29.60% | 35.46% | 21.63% | 11.58% | 12.13% | 15.59% | 13.60% | 11.14% | 8.02% | 8.93% | 10.02% | 8.88% | 8.52% | 10.29% | 16.59% | 21.75% | 20.09% | 26.01% | 26.82% | 21.63% | 21.58% | 18.39% | 23.01% | 23.50% |
| Research & Development | 44.90M | 28.56M | 21.09M | 37.48M | 13.60M | 51.03M | 40.46M | 15.52M | 6.65M | 5.16M | 2.86M | 15.14M | 5.36M | 3.63M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 40.36M | 39.36M | 30.56M | 47.26M | 38.19M | 54.11M | 37.61M | 27.48M | 28.00M | 29.57M | 30.97M | 26.22M | 25.52M | 39.57M | 98.85M | 81.86M | 83.40M | 88.53M | 69.25M | 66.88M | 60.72M | 47.72M | 42.20M | 22.92M | 26.70M | 15.01M | 12.25M | 11.36M |
| Selling & Marketing | 353.36M | 448.31M | 414.51M | 455.78M | 483.29M | 428.46M | 311.09M | 186.24M | 152.75M | 162.74M | 146.44M | 146.73M | 146.79M | 145.06M | 110.00M | 107.87M | 85.52M | 64.69M | 69.45M | 67.33M | 72.41M | 47.05M | 39.95M | 16.46M | 4.95M | 3.94M | 5.26M | 5.28M |
| SG&A | 501.30M | 487.67M | 445.07M | 503.04M | 521.48M | 482.57M | 348.70M | 213.72M | 180.76M | 192.31M | 177.41M | 172.94M | 172.31M | 184.64M | 208.85M | 189.72M | 168.92M | 153.22M | 138.70M | 134.21M | 133.13M | 94.77M | 82.15M | 39.38M | 31.65M | 18.95M | 17.51M | 16.64M |
| Other Expenses | 48.73M | 79.08M | 67.54M | 64.83M | 92.69M | -32.50M | 7.49M | 9.47M | 14.23M | 16.65M | 11.84M | 14.33M | 30.83M | 39.36M | -181.27K | 4.92M | 2.25M | 18.24M | 2.03M | 1.63M | 7.07M | 14.96M | 6.92M | 11.36M | 798.05K | 65.03K | 583.25K | 440.60K |
| Operating Expenses | 614.33M | 595.30M | 533.70M | 605.35M | 627.77M | 639.73M | 509.21M | 390.10M | 306.52M | 310.43M | 337.78M | 307.22M | 261.69M | 254.64M | 217.23M | 198.95M | 172.93M | 156.24M | 140.67M | 138.11M | 136.56M | 97.67M | 84.53M | 41.46M | 33.04M | 20.30M | 18.42M | 17.45M |
| Cost & Expenses | 2.31B | 2.04B | 1.80B | 1.90B | 2.11B | 1.74B | 2.83B | 3.92B | 2.88B | 2.90B | 3.69B | 3.62B | 3.83B | 3.34B | 2.29B | 2.47B | 2.35B | 1.81B | 1.33B | 1.06B | 1.04B | 590.64M | 573.81M | 366.11M | 269.40M | 269.07M | 182.00M | 193.21M |
| Interest Income | 4.07M | 4.64M | 1.85M | 4.88M | 4.52M | 8.20M | 7.63M | 6.76M | 5.69M | 6.16M | 4.90M | 6.95M | 11.24M | 4.91M | 5.73M | 10.79M | 9.33M | 16.61M | 5.86M | 7.34M | 3.64M | 3.83M | 5.89M | 6.49M | 0.00 | -0.49 | -0.78 | -0.90 |
| Interest Expense | 76.34M | 74.60M | 64.67M | 64.42M | 52.02M | 39.11M | 42.00M | 43.70M | 62.30M | 77.50M | 49.33M | 50.51M | 41.18M | 34.62M | 36.92M | 58.68M | 61.02M | 62.06M | 38.41M | 32.83M | 28.31M | 11.90M | 14.69M | 12.06M | 0.00 | 4.46M | 2.06M | 2.85M |
| Depreciation & Amortization | 45.89M | 49.29M | 51.33M | 87.70M | 91.00M | 85.92M | 84.95M | 65.82M | 57.90M | 46.74M | 40.83M | 39.97M | 37.84M | 39.82M | 38.10M | 38.32M | 44.19M | 41.85M | 33.18M | 27.96M | 21.50M | 16.42M | 13.94M | 13.77M | 11.80M | 6.28M | 629.49K | 2.61M |
| EBITDA | 47.49M | 48.98M | 146.55M | -352.07M | 214.16M | -96.06M | 310.11M | 159.23M | 205.60M | 258.75M | 240.32M | 189.72M | 134.99M | 125.03M | 106.38M | 111.88M | 56.27M | 132.99M | 127.52M | 157.96M | 127.19M | 113.26M | 125.26M | 74.67M | 43.81M | 39.38M | 30.47M | 36.53M |
| EBITDA Ratio | 2.12% | 2.32% | 2.83% | 2.70% | 10.93% | 16.21% | 10.73% | 4.02% | 7.23% | 7.96% | 6.39% | 5.64% | 4.22% | 4.99% | 5.19% | 4.76% | 4.10% | 7.17% | 9.60% | 13.36% | 11.29% | 16.87% | 18.74% | 19.93% | 14.43% | 13.78% | 14.34% | 15.90% |
| Operating Income | -32.58M | -583.09K | 578.77K | -32.97M | 144.00M | -190.44M | 176.06M | 39.40M | 71.23M | 116.59M | 138.88M | 85.20M | 47.93M | 37.79M | 26.27M | -5.72M | -51.06M | 21.64M | 65.67M | 97.50M | 76.47M | 78.28M | 96.57M | 50.59M | 40.02M | 32.19M | 29.84M | 33.92M |
| Operating Income Ratio | -1.45% | -0.03% | 0.03% | -1.76% | 6.82% | -11.19% | 5.95% | 0.99% | 2.43% | 3.80% | 3.58% | 2.29% | 1.24% | 1.12% | 1.14% | -0.23% | -2.14% | 1.17% | 4.59% | 8.30% | 6.78% | 11.75% | 14.45% | 12.21% | 13.28% | 10.56% | 14.05% | 14.76% |
| Total Other Income/Expenses | -44.46M | -267.21K | 2.73M | -23.08M | -66.71M | -32.50M | 7.49M | -26.81M | 14.17M | 16.35M | 11.22M | 14.04M | 8.00M | 6.84M | 3.04M | 20.54M | -32.74M | 6.78M | -38.76M | -2.20M | 908.85K | 5.76M | 65.12K | -1.74M | 422.79K | -2.42M | 179.12K | 206.27K |
| Income Before Tax | -77.04M | -75.40M | 39.24M | -504.12M | 77.29M | -222.94M | 183.55M | 47.84M | 85.40M | 132.94M | 150.10M | 99.24M | 55.93M | 44.63M | 29.31M | 14.82M | -49.16M | 28.60M | 65.76M | 96.11M | 77.37M | 84.06M | 96.64M | 56.50M | 40.44M | 32.03M | 30.02M | 34.12M |
| Income Before Tax Ratio | -3.44% | -3.72% | 2.21% | -26.93% | 3.66% | -13.10% | 6.20% | 1.20% | 2.92% | 4.34% | 3.87% | 2.67% | 1.44% | 1.32% | 1.27% | 0.59% | -2.06% | 1.55% | 4.60% | 8.19% | 6.87% | 12.62% | 14.45% | 13.64% | 13.42% | 10.51% | 14.13% | 14.85% |
| Income Tax Expense | 3.26M | 2.83M | 18.60M | 3.47M | 15.52M | 59.38M | 48.29M | -30.21M | 22.42M | 46.11M | 56.81M | 34.31M | 15.01M | 11.01M | 9.05M | 2.76M | 8.37M | 8.91M | 12.84M | 16.27M | 24.29M | 23.64M | 12.79M | 8.26M | 5.72M | 595.88K | -1.03M | -2.85M |
| Net Income | -71.95M | -78.23M | 22.72M | -507.60M | 64.53M | -285.57M | 133.11M | 72.00M | 49.11M | 40.85M | 50.54M | 46.84M | 30.87M | 29.30M | 14.57M | 6.85M | -64.33M | 15.76M | 35.03M | 54.58M | 52.03M | 60.18M | 83.20M | 47.96M | 34.59M | 31.43M | 30.02M | 34.12M |
| Net Income Ratio | -3.21% | -3.86% | 1.28% | -27.12% | 3.06% | -16.78% | 4.50% | 1.80% | 1.68% | 1.33% | 1.30% | 1.26% | 0.80% | 0.87% | 0.63% | 0.27% | -2.70% | 0.85% | 2.45% | 4.65% | 4.62% | 9.03% | 12.44% | 11.58% | 11.47% | 10.31% | 14.13% | 14.85% |
| EPS | -0.10 | -0.11 | 0.03 | -0.72 | 0.09 | -0.40 | 0.19 | 0.11 | 0.08 | 0.07 | 0.08 | 0.08 | 0.05 | 0.05 | 0.02 | 0.01 | -0.10 | 0.02 | 0.05 | 0.06 | 0.06 | 0.06 | 0.09 | 0.05 | 0.04 | 0.06 | 0.07 | 0.08 |
| EPS Diluted | -0.10 | -0.11 | 0.03 | -0.72 | 0.09 | -0.40 | 0.19 | 0.11 | 0.08 | 0.07 | 0.08 | 0.08 | 0.05 | 0.05 | 0.02 | 0.01 | -0.10 | 0.02 | 0.05 | 0.06 | 0.06 | 0.06 | 0.09 | 0.05 | 0.04 | 0.06 | 0.07 | 0.08 |
| Weighted Avg Shares Out | 719.45M | 712.32M | 704.56M | 704.56M | 717.04M | 713.92M | 719.49M | 683.80M | 637.83M | 628.46M | 623.92M | 624.49M | 629.92M | 623.44M | 633.34M | 622.73M | 624.54M | 619.54M | 413.86M | 413.86M | 413.86M | 413.86M | 413.86M | 413.86M | 413.86M | 413.86M | 413.86M | 413.86M |
| Weighted Avg Shares Out (Dil) | 719.45M | 712.32M | 704.56M | 704.56M | 717.04M | 713.92M | 719.49M | 685.68M | 637.83M | 628.46M | 623.92M | 624.49M | 629.92M | 623.44M | 633.34M | 622.73M | 624.54M | 619.54M | 413.86M | 413.86M | 413.86M | 413.86M | 413.86M | 413.86M | 413.86M | 413.86M | 413.86M | 413.86M |
No news found for: 600200.SS
Source: https://incomestatements.info
Category: Stock Reports